Bemnifosbuvir hemisulfate, CAS [[2241337-84-6]]
Artikelnummer:
BYT-ORB1298178
Produktübersicht
Artikelname:
Bemnifosbuvir hemisulfate, CAS [[2241337-84-6]]
Artikelnummer:
BYT-ORB1298178
Hersteller Artikelnummer:
orb1298178
Alternativnummer:
BYT-ORB1298178-1, BYT-ORB1298178-10, BYT-ORB1298178-100, BYT-ORB1298178-200, BYT-ORB1298178-25, BYT-ORB1298178-5, BYT-ORB1298178-50
Hersteller:
Biorbyt
Kategorie:
Biochemikalien
Alternative Synonym:
Bemnifosbuvir, Bemnifosbuvir hemisulfate, Bemnifosbuvir Hemisulfate, antiviral, AT 527, AT527, AT-527, HCVProtease, HCV, HCV Protease, Hepatitis C virus, guanosine, Inhibitor, inhibit, pangenotypic, nucleotide, phosphoramidate, SARS coronavirus, SARSCoV, SARS-CoV, SARS-CoV-2
Produktbeschreibung
Bemnifosbuvir hemisulfate (AT-527) is a direct-acting antiviral nucleotide prodrug that potently inhibits hepatitis C virus (HCV) replication. It has demonstrated antiviral activity in both in vitro assays and in vivo clinical studies, making it a valuable tool for HCV research.
Produkteigenschaften
Molekulargewicht:
1261.15
Reinheit:
99.98% (May vary between batches)
CAS Nummer:
[2241337-84-6]
Formel:
C48H68F2N14O18P2S
Target-Kategorie:
SARS-CoV,HCV Protease
Anwendungsbeschreibung
Anwendungsbeschreibung:
Solubility: DMSO:170 mg/mL (134.8 mM),10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (3.96 mM)
